Kathy Cundiff
Visit Investigator ProfileInvestigation Details
Detailed Analysis
Kathy Cundiff meticulously evaluates the clinical trial data, treatment success rates, and potential systemic effects. She places a strong emphasis on the clarity and thoroughness of treatment protocols and the adequacy of follow-up procedures.
Kathy Cundiff is a detail-oriented auditor with a focus on clinical trial data, treatment success rates, and potential systemic effects. She prioritizes clear guidance on indications, dosing, administration, and education for physicians and caregivers. Kathy also emphasizes the need for thorough follow-up and monitoring, especially when off-label treatments are involved.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies